OverviewSuggest Edit

uniQure is focused on the research and early development of human gene-based therapies. It develops treatment and platform for patients suffering from genetic and other devastating diseases. The Company's products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases.

HQAmsterdam, NL
Employee Ratings2.3

Latest Updates

Employees (est.) (Jul 2021)332
Share Price (Sept 2021)$35.9(-5%)
Cybersecurity ratingBMore

Key People/Management at UniQure

Jack Kaye

Jack Kaye

Non-Executive Director
Jonathan Garen

Jonathan Garen

Chief Business Officer
Paula Soteropoulos

Paula Soteropoulos

Non-Executive Director
Maria E. Cantor

Maria E. Cantor

Chief Communications Officer
Madhavan Balachandran

Madhavan Balachandran

Non-Executive Director
Jeremy Springhorn

Jeremy Springhorn

Non-Executive Director
Show more

UniQure Office Locations

UniQure has an office in Amsterdam
Amsterdam, NL (HQ)
Paasheuvelweg 25a
Show all (1)

UniQure Financials and Metrics

UniQure Revenue

Market capitalization (23-Sept-2021)


Closing stock price (23-Sept-2021)

UniQure's current market capitalization is $1.7 b.
Show all financial metrics

UniQure Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

UniQure Online and Social Media Presence

Embed Graph

UniQure News and Updates

UniQure stock is up after FDA lifts clinical hold on experimental gene therapy

Shares of UniQure gained 9.1% in trading on Monday after the company said the Food and Drug Administration had lifted a clinical hold on the hemophilia B program for its experimental gene therapy. UniQure said it now expects to share top-line data from the clinical trial sometime this quarter. The …

UniQure NV weighs options including sale -Bloomberg

Gene therapy company UniQure NV is exploring options including a sale amid interest from other pharmaceutical companies looking to expand in gene therapy, Bloomberg reported on Sunday citing people with knowledge of the matter.

UniQure Frequently Asked Questions

  • When was UniQure founded?

    UniQure was founded in 1998.

  • Who are UniQure key executives?

    UniQure's key executives are Jack Kaye, Jonathan Garen and Paula Soteropoulos.

  • How many employees does UniQure have?

    UniQure has 332 employees.

  • Who are UniQure competitors?

    Competitors of UniQure include Synchronicity Pharma, Marsala Biotech and Neuren Pharmaceuticals.

  • Where is UniQure headquarters?

    UniQure headquarters is located at Paasheuvelweg 25a, Amsterdam.

  • Where are UniQure offices?

    UniQure has an office in Amsterdam.

  • How many offices does UniQure have?

    UniQure has 1 office.